Endometriosis Treatment Market is poised to register a CAGR of 10% during the forecast period 2022 to 2028.    

Rise in the female population within the reproductive age, growing awareness amongst women regarding the disease, the availability of novel drugs for treating endometriosis are some of the factors contributing to the growth of the market. Endometriosis is very painful and can result into infertility. It affects the outlined tissues of the uterus and causes internal bleeding and inflammation. However, it takes over seven years to even diagnose the disease and the unavailability of non-invasive diagnostic tests shall increase the patient’s suffering. Therefore, this factor shall possibly restrain the endometriosis treatment market growth. Furthermore, many key market players are conducting extensive researches in developing advanced drugs and treatment methodologies for endometriosis keeping cost management into consideration. Such initiatives undertaken by major market players shall propel the market growth. 

Market Segmentation:

By Drug Type
•    Progestin 
•    Gonadotropins Releasing Hormone Agonists
•    Oral Contraceptive Pills
•    Non-Steroidal Anti-Inflammatory Drugs    
By Distribution Channel
•    Pain Management 
•    Hormonal Therapies
By Treatment Type
•    Drug Stores
•    Hospital Pharmacies
•    Mail Order Pharmacies
•    E-Pharmacies
•    Retail Pharmacies
•    Others
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into drug type, distribution channel, treatment type and region. The drug type segment is bifurcated into progestin, gonadotropins releasing hormone agonists, oral contraceptive pills, non-steroidal ani-inflammatory drugs. The oral contraceptive pills segment is predicted to account the largest endometriosis treatment market share as it is a highly preferred treatment method owing to their efficacy of preventing the recurrence of endometriosis lesions and pelvic pain. But there are side effects of these pills like mood swings, elevated blood pressure and nausea. The progestins are required to be consumed intermittently unlike oral contraceptives that should be consumed regularly. The treatment segment is fragmented into pain management and hormonal therapies. The distribution channel segment is bifurcated into drug stores, hospital pharmacies, mail order pharmacies, e-pharmacies, retail pharmacies and others.

Regional Analysis:

The North America region is predicted to dominate the market during the forecast period and this can be credited to the rising population capable of reproducing, increased patient number diagnosed with endometriosis, high losses owing to disability and key market players have a stronghold in the region.  The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecasted timeframe owing to key market players expanding their businesses in the region. 

Competitive Landscape:                            

The major market players associated are Eli Lilly and Company, AstraZeneca Plc., Bayer AG, Astellas Pharma, Abbvie, Meditrina Pharmaceuticals, Pfizer Inc., Neurocrine Biosciences Inc., Takeda Pharmaceutical Company.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global endometriosis treatment market by drug type, by distribution channel, by treatment type and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions            

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics